KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Cerebral venous thrombosis with clinical, etiological and radiological findings
Aims: Thrombosis of the cerebral veins is a disease that can be caused by many factors and puts clinicians in a difficult situation during diagnosis and treatment. Our study investigated clinical findings, etiological causes, localization of thrombosis detected by neuroimaging tests, and the treatments received by the patients with cerebral venous thrombosis who were followed up as inpatients in our clinic.
Methods: We retrospectively analyzed 44 patients between the ages of 18-80 years who were hospitalized with a diagnosis of cerebral venous thrombosis. Age, duration of admission, initial symptoms, neurological examination findings, Glasgow Coma Scale values at admission, etiological causes, topographic areas of involvement in neuroradiological examinations, and inpatient medical treatment were analyzed.
Results: Forty-four patients (26 females, 18 males) with cerebral venous thrombosis were included in our study. According to the duration of presentation, 47.7% presented in the subacute period. Headache was the most common presenting symptom, with a rate of 90.9%, while nausea and vomiting (68.2%) and papilledema (54.5%) were the other common symptoms. Multiple vein and/or sinus involvement was present in all 17 patients with seizures. The most common etiological factors were thrombophilia (54.5%), pregnancy and the postpartum period (18.8%), and oral contraceptive use (15.9%). Multiple sinus involvement was observed in 41 patients (93.2%), while three had single sinus involvement. The rate of sinus involvement was 86.4% (38 patients) in the transverse sinus, 77.3% (34 patients) in the sigmoid sinus, and 52.3% (23 patients) in the superior sagittal sinus.
Conclusion: Cerebral venous thrombosis has many etiological causes that can be overlooked due to the variety of clinical manifestations and changes in the prognosis when treated. Early treatment is essential because it can reduce the risk of death and severe disability. Our study is critical because it covers a relatively large number of cases.


1. Aguiar de Sousa D. Cerebral venous thrombosis: what’s new?. Hamostaseologie. 2021;41(1):25-30.
2. Kamışlı Ö, Arslan D, Altınayar S, et al. Serebral venöz sinüs trombozu: klinik değerlendirme. J Turk Cerebrovasc Dis. 2009;15(2):39-42.
3. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005; 352(17):1791-1798.
4. Gulati D, Strbian D, Sundararajan S. Cerebral venous thrombosis: diagnosis and management. Stroke. 2014;45(2):16-18.
5. Borhani-Haghighi A, Hooshmandi E. Cerebral venous thrombosis: a practical review. Postgrad Med J. 2024;100(1180):68-83.
6. Koennecke HC. Cerebral venous thrombosis in adults. Vasa. 2019;48(6): 473-482.
7. Kristoffersen ES, Harper CE, Vetvik KG, Faiz KW. Cerebral venous thrombosis-epidemiology, diagnosis and treatment. Cerebral venetrombose-forekomst, diagnostikk og behandling. Tidsskr Nor Laegeforen. 2018;138(12): 10.4045/tidsskr.17.1047.
8. Domaç FM, Mısırlı H, Adıgüzel T, et al. Serebral venöz sinüs trombozunda klinik etyoloji ve prognoz. Turk J Neurol. 2008;14(1):27-32.
9. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664-670.
10. Duman T, Uluduz D, Midi I, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis. 2017;26(8):1848-1857.
11. Agostoni E. Headache in cerebral venous thrombosis. Neurol Sci. 2004; 25(Suppl 3):S206-S210.
12. Bogousslavsky J, Caplan L. Stroke syndromes. In: Arquizan C, ed. Brain venous thrombosis syndromes. 2nd ed. Cambridge University Press; 2001: 626-651.
13. Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-1192.
14. Luo Y, Tian X, Wang X. Diagnosis and treatment of cerebral venous thrombosis: a review.Front Aging Neurosci. 2018;10:2.
15. Mehndiratta P, Koubeissi M. Seizures in Cerebral Venous Sinus Thrombosis. In: Seizures in Cerebrovascular Disorders. Springer; 2015:95-101.
16. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: what predicts it?Epilepsy Res. 2016;123:1-5.
17. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102(4): 1363-1366.
18. Yokuş O, Şahin Balçık Ö, Albayrak M, et al. Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis. Serebral venöz tromboz geçiren hastaların trombofilik risk faktörleri açısından değerlendirilmesi.Turk J Haematol. 2010;27(3):162-167.
19. Zuurbier SM, Coutinho JM. Cerebral venous thrombosis.Adv Exp Med Biol. 2017;906:183-193.
20. Lüdemann P, Nabavi DG, Junker R, et al. Factor V leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998;29(12):2507-2510.
21. Amaral FM, Silva CR, Borém MG, Miranda-Vilela AL. Cerebral venous thrombosis in young adult with familial protein S deficiency. Blood Coagul Fibrinolysis. 2015;26(3):342-345.
22. Wysokinska EM, Wysokinski WE, Brown RD, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 2008;70(8):627-633.
23. Öztürk V. Serebral venöz tromboz. J Neurol Sci. 2007;24(1):5-6.
24. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol. 2000;247(4):252-258.
25. Giray S, Arlıer Z. Dural sinüs trombozları: klinik nörogörüntüleme medikal-endovasküler tedavi. Turkiye Klinikleri J Neurol-Special Topics. 2011;4(3):114-122.
26. Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369-379.
27. Cantú C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Stroke. 1993;24(12): 1880-1884.
28. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol. 2017; 24(10):1203-1213.
Volume 4, Issue 4, 2024
Page : 146-151
_Footer